WisdomTree Insights

At WisdomTree, we work with Dr. Jamie Metzl on a strategy that we term the BioRevolution. Dr. Metzl recently a book, Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform our Lives, Work, and World. In the third part of our BioRevolution blog series, Christopher Gannatti summarizes a few key points from the book including the evolution of AlphaFold 3. 
Read the article
Nvidia isn’t the only player in the semiconductor field. Christopher Gannatti and Mobeen Tahir highlight other companies making significant strides in the semiconductor industry.
Read the article
Late 2023 was a period of high hopes for interest rate cuts from the U.S. Federal Reserve. Christopher Gannatti discusses the resulting boom in SaaS stocks and their subsequent decline in the first half of 2024. 
Read the article
At WisdomTree, we work with Dr. Jamie Metzl on a strategy that we term the BioRevolution. Dr. Metzl recently wrote a book, Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform our Lives, Work, and World. In this second part of our BioRevolution blog series, Christopher Gannatti summarizes a few key points from the book including the journey to the mRNA vaccine.
Read the article
At WisdomTree, we work with Dr. Jamie Metzl on a strategy that we term the BioRevolution. Dr. Metzl recently wrote a book, Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform our Lives, Work, and World. Christopher Gannatti summarizes a few key points from the book including the potential of the self-driving lab. 
Read the article
Every year, WisdomTree's expert partner behind the BVP Nasdaq Emerging Cloud Index, Bessemer Venture Partners (BVP), releases a State of the Cloud report. Christopher Gannatti highlights some key ideas from this year's report, like AI defining the cloud in 2024. 
Read the article